Daito Pharmaceutical Co Ltd

TSE:4577 (Japan)  
円 2497.00 (-0.04%) Apr 23
On watch
12.03
P/B:
0.75
Market Cap:
円 39.06B ($ 252.25M)
Enterprise V:
円 42.58B ($ 274.98M)
Volume:
69.80K
Avg Vol (2M):
58.61K
Warning! GuruFocus detected 2 Severe warning signs with 4577. Try a 7-Day Free Trial to check it out.
Volume:
69.80K
Market Cap 円:
39.06B
Market Cap $:
252.25M
12.03
Avg Vol (2M):
58.61K
Enterprise Value 円:
42.58B
Enterprise Value $:
274.98M
PB Ratio:
0.75
Alerts Website Sources Stock PDF
Dataset
Financial Download Manual of Stocksâ„¢

Business Description

Daito Pharmaceutical Co Ltd

ISIN : JP3486150000
http://www.daitonet.co.jp
326 Yokamachi, Toyama, JPN, 939-8567
Compare
Compare
TSE:9273TSE:4595TSE:4554TSE:2929TSE:4538TSE:4574TSE:4886TSE:4582TSE:4524TSE:4512ZTSXTER:MRKTSE:4502LSE:HLNNSE:SUNPHARMATSE:4523TSE:4507SZSE:000538XSWX:SDZHKSE:03692
Traded in other countries / regions
4577.Japan
IPO Date
2010-03-24
Description
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.52
Equity-to-Asset 0.67
Debt-to-Equity 0.14
Debt-to-EBITDA 1.61
Interest Coverage 182.91
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.72
Distress
Grey
Safe
Beneish M-Score -2.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

7/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -3.7
3-Year EBITDA Growth Rate -2.3
3-Year EPS without NRI Growth Rate -5.3
3-Year Book Growth Rate 8.2

Momentum Rank

7/10
Name Current Vs Industry Vs History
5-Day RSI 75
9-Day RSI 74.15
14-Day RSI 74.03
6-1 Month Momentum % 19.59
12-1 Month Momentum % -1.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.29
Quick Ratio 1.15
Cash Ratio 0.2
Days Inventory 198.42
Days Sales Outstanding 93.71
Days Payable 59.05

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 2.29
Dividend Payout Ratio 0.3
3-Year Dividend Growth Rate 14.5
Forward Dividend Yield % 2.4
5-Year Yield-on-Cost % 4.04
3-Year Average Share Buyback Ratio -3.1
Shareholder Yield % -0.39

Profitability Rank

7/10
Name Current Vs Industry Vs History
Gross Margin % 21.38
Operating Margin % 9.31
Net Margin % 7.26
FCF Margin % -3.1
ROE % 6.43
ROA % 4.52
ROIC % 4.79
ROC (Joel Greenblatt) % 9.05
ROCE % 8.06
Years of Profitability over Past 10-Year 10

GF Value Rank

9/10
Name Current Vs Industry Vs History
PE Ratio 12.03
PE Ratio without NRI 12.9
Shiller PE Ratio 9.99
PEG Ratio 4.45
PS Ratio 0.87
PB Ratio 0.75
Price-to-Tangible-Book 0.76
Price-to-Operating-Cash-Flow 9.51
EV-to-EBIT 9.38
EV-to-EBITDA 9.38
EV-to-Revenue 0.94
EV-to-FCF -30.01
Price-to-Projected-FCF 0.82
Price-to-Median-PS-Value 0.97
Price-to-Graham-Number 0.66
Price-to-Net-Current-Asset-Value 2.25
Earnings Yield (Greenblatt) % 10.66
FCF Yield % -3.59
Forward Rate of Return (Yacktman) % 4.68

Financials

TSE:4577's 30-Y Financials
AAPL
Income Statement Breakdown
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Daito Pharmaceutical Co Ltd Executives

Details

GF Value: 円2455.1

TSE:4577

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 45,193
EPS (TTM) (円) 207.687
Beta 0.47
Volatility % 26.98
14-Day RSI 74.03
14-Day ATR (円) 59.0795
20-Day SMA (円) 2382.7
12-1 Month Momentum % -1.89
52-Week Range (円) 1803 - 2517
Shares Outstanding (Mil) 15.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Daito Pharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Daito Pharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Daito Pharmaceutical Co Ltd Frequently Asked Questions

What is Daito Pharmaceutical Co Ltd(TSE:4577)'s stock price today?
The current price of TSE:4577 is 円2497.00. The 52 week high of TSE:4577 is 円2517.00 and 52 week low is 円1803.00.
When is next earnings date of Daito Pharmaceutical Co Ltd(TSE:4577)?
The next earnings date of Daito Pharmaceutical Co Ltd(TSE:4577) is .
Does Daito Pharmaceutical Co Ltd(TSE:4577) pay dividends? If so, how much?
The  Dividend Yield %  of Daito Pharmaceutical Co Ltd(TSE:4577) is 2.29% (As of Today), Highest Dividend Payout Ratio of Daito Pharmaceutical Co Ltd(TSE:4577) was 0.3. The lowest was 0.13. And the median was 0.14. The  Forward Dividend Yield % of Daito Pharmaceutical Co Ltd(TSE:4577) is 2.4%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.